Publications by the researcher in collaboration with ELIZABETH HIJONA MURUAMENDIARAZ (13)
2021
-
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
Gut, Vol. 70, Núm. 7, pp. 1345-1361
2019
-
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Gut, Vol. 68, Núm. 3, pp. 533-546
2017
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
2016
-
Effect of pravastatin on the survival of patients with advanced gastric cancer
Oncotarget, Vol. 7, Núm. 4, pp. 4379-4384
2015
-
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961
2014
-
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases
Gut, Vol. 63, Núm. 10, pp. 1658-1667
-
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery
BMC Medicine, Vol. 12, Núm. 1
-
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4
2013
2012
-
COGENT (COlorectal cancer GENeTics) revisited
Mutagenesis, Vol. 27, Núm. 2, pp. 143-151
-
Effect of neoadjuvant chemotherapy in hepatic steatosis
Chemotherapy, Vol. 58, Núm. 2, pp. 89-94
2010
-
Colorectal cancer prognosis twenty years later
World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867
2009
-
Características clinicopatológicas y supervivencia de los pacientes con cáncer de esófago. Resultados de 200 casos consecutivos
Medicina Clinica, Vol. 133, Núm. 18, pp. 689-693